CRISPR Gene-Editing Tested In a Person for the First Time
Nov 16, 2016 0:08:40 GMT
actcrazy and iamaverb like this
Post by tatshensini on Nov 16, 2016 0:08:40 GMT
www.scientificamerican.com/article/crispr-gene-editing-tested-in-a-person-for-the-first-time/?print=true
CRISPR Gene-Editing Tested In a Person for the First Time
The move by Chinese scientists could spark a biomedical duel between China and the United States
A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique.
On October 28, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.
Earlier clinical trials using cells edited with a different technique have excited clinicians. The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world, says Carl June, who specializes in immunotherapy at the University of Pennsylvania in Philadelphia and led one of the earlier studies.
"I think this is going to trigger ‘Sputnik 2.0’, a biomedical duel on progress between China and the United States, which is important since competition usually improves the end product,” he says.
June is the scientific adviser for a planned US trial......
CRISPR Gene-Editing Tested In a Person for the First Time
The move by Chinese scientists could spark a biomedical duel between China and the United States
A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique.
On October 28, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.
Earlier clinical trials using cells edited with a different technique have excited clinicians. The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world, says Carl June, who specializes in immunotherapy at the University of Pennsylvania in Philadelphia and led one of the earlier studies.
"I think this is going to trigger ‘Sputnik 2.0’, a biomedical duel on progress between China and the United States, which is important since competition usually improves the end product,” he says.
June is the scientific adviser for a planned US trial......
